Cargando…
Molecular basis for dengue virus broad cross-neutralization by humanized monoclonal antibody 513
Dengue is a widespread viral disease with 3.6 billion people at risk worldwide. Humanized monoclonal antibody (mAb) 513, currently undergoing clinical trials in Singapore, targets an epitope on the envelope protein domain III exposed at the surface of the viral particle. This antibody potently neutr...
Autores principales: | Wong, Yee Hwa, Kumar, Akshita, Liew, Chong Wai, Tharakaraman, Kannan, Srinivasaraghavan, Kannan, Sasisekharan, Ram, Verma, Chandra, Lescar, Julien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5981469/ https://www.ncbi.nlm.nih.gov/pubmed/29855525 http://dx.doi.org/10.1038/s41598-018-26800-y |
Ejemplares similares
-
Glycan–protein interactions in viral pathogenesis
por: Raman, Rahul, et al.
Publicado: (2016) -
Antigenically intact hemagglutinin in circulating avian and swine influenza viruses and potential for H3N2 pandemic
por: Tharakaraman, Kannan, et al.
Publicado: (2013) -
Prediction of the structural interface between fibroblast growth factor23 and Burosumab using alanine scanning and molecular docking
por: Kanhasut, Karnpob, et al.
Publicado: (2022) -
An inter-residue network model to identify mutational-constrained regions on the Ebola coat glycoprotein
por: Quinlan, Devin S., et al.
Publicado: (2017) -
Modified recombinant human erythropoietin with potentially reduced immunogenicity
por: Susantad, Thanutsorn, et al.
Publicado: (2021)